Olympus reviewed the following article: "demarcation of early esophageal squamous cell carcinoma during endoscopic submucosal dissection: a comparison study between lugol's iodine staining and narrow-band imaging." this was a single-center, retrospective, cohort study was aimed to investigate and compare the effects on clinical outcomes between lugol¿s iodine staining (lis) and narrow-band imaging (nbi) are in the demarcation of early esophageal squamous cell carcinoma (eesccs) during endoscopic submucosal dissection and provide evidence to direct future clinical practice.A total of 172 consecutive patients were included and received two different margin determinations of the lesion, lis (n=109) and nbi (n=63).Data on clinical outcomes, adverse events, and follow-up information were collected for analysis.The study revealed that all patients underwent esd successfully with a mean procedure time of 52.5±38.1 minutes.The reported rates for en bloc and r0 resection was 100% and 89.5%, respectively.A total of 44 (25.6%) patients suffered adverse events, including 16 (9.3%) patients with in-hospital adverse events and 39 (22.7%) with esophageal stenosis.In conclusion, the study supported and recommended nbi as it was more convenient, lower efficient and without the risks raised by lugol¿s solution, also demonstrated efficacy in the demarcation of eesccs during esd, which showed a comparable accuracy and clinical outcomes with lis. the adverse events reported (number of patients): [lugol¿s iodine group; n=109], total adverse events - (30), esophageal stenosis - (26), in-hospital adverse events - (12), fever (> 38°c) - (9), bleeding - (4), perforation - (2), mediastinal emphysema - (4), subcutaneous emphysema - (4), pleural effusion - (5), pneumothorax - (2), recurrence - (2).[nbi group; n=63], total adverse events - (14), esophageal stenosis - (13), in-hospital adverse events - (4), fever (> 38°c) - (2), bleeding - (2), perforation - (1), mediastinal emphysema - (1), subcutaneous emphysema - (1), pleural effusion - (1), pneumothorax - (1), esophageal fistula - (1), recurrence - (3), [follow-up], death - (2).The authors used multiple olympus devices and did not specify the device in association to the group of adverse events.Therefore, this article includes 6 reports: (b)(6) pw-5l adverse event from the lugol¿s iodine group and the nbi group.(b)(6) pw-5l deaths (n=2).(b)(6) gif-q260j adverse events from the lugol¿s iodine group and the nbi group.(b)(6) gif-q260j deaths (n=2).(b)(6) gif-h260z adverse event from the nbi group only.(b)(6) gif-h260z deaths (n=2).This report is for: (b)(6) gif-h260z deaths (n=2).
|